Kaiyao Hua

1.0k total citations
27 papers, 739 citations indexed

About

Kaiyao Hua is a scholar working on Molecular Biology, Cancer Research and Cell Biology. According to data from OpenAlex, Kaiyao Hua has authored 27 papers receiving a total of 739 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 15 papers in Cancer Research and 7 papers in Cell Biology. Recurrent topics in Kaiyao Hua's work include Cancer-related molecular mechanisms research (11 papers), MicroRNA in disease regulation (11 papers) and Circular RNAs in diseases (9 papers). Kaiyao Hua is often cited by papers focused on Cancer-related molecular mechanisms research (11 papers), MicroRNA in disease regulation (11 papers) and Circular RNAs in diseases (9 papers). Kaiyao Hua collaborates with scholars based in China, Australia and United States. Kaiyao Hua's co-authors include Lin Fang, Hongming Song, Jialu Song, Hui Xu, Changle Ji, Jiashu Hu, Dengfeng Li, Chenyang Wu, Bingkun Zhao and Xiaochong Deng and has published in prestigious journals such as The International Journal of Biochemistry & Cell Biology, BioMed Research International and Cell Death and Disease.

In The Last Decade

Kaiyao Hua

26 papers receiving 730 citations

Peers

Kaiyao Hua

ONCOL

IMMUN

Daniela Schwarzenbacher Austria

Jiadong Chi China

Stine Jørgensen Denmark

Paul D. Cao United States

Gen-ichi Kusakai Japan

Hezhe Lu China

Hezhao Zhao China

Nastaran Mohammadi Ghahhari Iran

Jingxin Feng China

Daniela Schwarzenbacher Austria

Kaiyao Hua

493 ×0.8

425 ×0.9

101 ×1.1

ONCOL

25 ×0.3

39 ×1.0

IMMUN

Citations per year, relative to Kaiyao Hua Kaiyao Hua (= 1×) peers Daniela Schwarzenbacher

Countries citing papers authored by Kaiyao Hua

Since Specialization

Citations

This map shows the geographic impact of Kaiyao Hua's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaiyao Hua with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaiyao Hua more than expected).

Fields of papers citing papers by Kaiyao Hua

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaiyao Hua. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaiyao Hua. The network helps show where Kaiyao Hua may publish in the future.

Co-authorship network of co-authors of Kaiyao Hua

This figure shows the co-authorship network connecting the top 25 collaborators of Kaiyao Hua. A scholar is included among the top collaborators of Kaiyao Hua based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaiyao Hua. Kaiyao Hua is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Xuehui, et al.. (2024). LncRNA HOST2 promotes NSUN2-mediated breast cancer progression via interaction with ELAVL1. Cellular Signalling. 117. 111112–111112. 8 indexed citations

Jin, Jiali, Lin Lü, Kaiyao Hua, et al.. (2024). Correlations between SHBG, Sex Hormones, Inflammation, and Neurocognitive Decline in Alzheimer's Disease: A Retrospective Study. Current Alzheimer Research. 21(7). 491–502.

Deng, Xiaochong, et al.. (2023). E2F1-mediated ectopic expression of PP1A promotes breast cancer progression via activation of YAP1. The International Journal of Biochemistry & Cell Biology. 157. 106389–106389. 4 indexed citations

Yu, Yunhe, Wenfang Zheng, Changle Ji, et al.. (2022). Tumor-Derived circRNAs as Circulating Biomarkers for Breast Cancer. Frontiers in Pharmacology. 13. 811856–811856. 15 indexed citations

Wang, Xuehui, Changle Ji, Jiashu Hu, et al.. (2021). Hsa_circ_0005273 facilitates breast cancer tumorigenesis by regulating YAP1-hippo signaling pathway. Journal of Experimental & Clinical Cancer Research. 40(1). 29–29. 57 indexed citations

Deng, Xiaochong, Kaiyao Hua, Hongming Song, et al.. (2021). MIR22HG inhibits breast cancer progression by stabilizing LATS2 tumor suppressor. Cell Death and Disease. 12(9). 810–810. 17 indexed citations

Li, Yuan, Kaiyao Hua, Jiali Jin, & Lin Fang. (2021). miR‑497 inhibits proliferation and invasion in triple‑negative breast cancer cells via YAP1. Oncology Letters. 22(2). 580–580. 10 indexed citations

Hua, Kaiyao, Xiaochong Deng, Jiashu Hu, et al.. (2020). Long noncoding RNA HOST2, working as a competitive endogenous RNA, promotes STAT3-mediated cell proliferation and migration via decoying of let-7b in triple-negative breast cancer. Journal of Experimental & Clinical Cancer Research. 39(1). 58–58. 42 indexed citations

Wu, Tianqi, Hongming Song, Dan Xie, et al.. (2020). Mir‐30b‐5p Promotes Proliferation, Migration, and Invasion of Breast Cancer Cells via Targeting ASPP2. BioMed Research International. 2020(1). 7907269–7907269. 17 indexed citations

10.

Hu, Jiashu, Changle Ji, Kaiyao Hua, et al.. (2020). Hsa_circ_0091074 regulates TAZ expression via microRNA‑1297 in triple negative breast cancer cells. International Journal of Oncology. 56(5). 1314–1326. 22 indexed citations

11.

Xie, Dan, Hongming Song, Tianqi Wu, et al.. (2018). MicroRNA‑424 serves an anti‑oncogenic role by targeting cyclin‑dependent kinase�1 in breast cancer cells. Oncology Reports. 40(6). 3416–3426. 50 indexed citations

12.

Wu, Tianqi, Hongming Song, Dan Xie, et al.. (2018). Silencing of ASPP2 promotes the proliferation, migration and invasion of triple-negative breast cancer cells via the PI3K/AKT pathway. International Journal of Oncology. 52(6). 2001–2010. 17 indexed citations

13.

Maskey, Niraj, Dengfeng Li, Hui Xu, et al.. (2017). MicroRNA-340 inhibits invasion and metastasis by downregulating ROCK1 in breast cancer cells. Oncology Letters. 14(2). 2261–2267. 39 indexed citations

14.

Xu, Hui, Mingping Qian, Bingkun Zhao, et al.. (2017). Inhibition of RAB1A suppresses epithelial-mesenchymal transition and proliferation of triple-negative breast cancer cells. Oncology Reports. 37(3). 1619–1626. 31 indexed citations

15.

Hua, Kaiyao, Jiali Jin, Huiwen Zhang, et al.. (2016). MicroRNA-7 inhibits proliferation, migration and invasion of thyroid papillary cancer cells via targeting CKS2. International Journal of Oncology. 49(4). 1531–1540. 49 indexed citations

16.

Hua, Kaiyao, Jiali Jin, Junyong Zhao, et al.. (2016). miR-135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2. International Journal of Oncology. 48(5). 1997–2006. 69 indexed citations

17.

Song, Hongming, Jialu Song, Deng‐Feng Li, et al.. (2015). Inhibition of FOXO1 by small interfering RNA enhances proliferation and inhibits apoptosis of papillary thyroid carcinoma cells via Akt/FOXO1/Bim pathway. OncoTargets and Therapy. 8. 3565–3565. 26 indexed citations

18.

Wei, Chuankui, Hongming Song, Dengfeng Li, et al.. (2015). miR-183 regulates biological behavior in papillary thyroid carcinoma by targeting the programmed cell death 4. Oncology Reports. 34(1). 211–220. 27 indexed citations

19.

Song, Hongming, Chenyang Wu, Chuankui Wei, et al.. (2015). Silencing of DUSP6 gene by RNAi-mediation inhibits proliferation and growth in MDA-MB-231 breast cancer cells: an in vitro study.. PubMed. 8(7). 10481–90. 16 indexed citations

20.

Song, Hongming, Yi Luo, Dengfeng Li, et al.. (2015). MicroRNA-96 plays an oncogenic role by targeting FOXO1 and regulating AKT/FOXO1/Bim pathway in papillary thyroid carcinoma cells.. PubMed. 8(9). 9889–900. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact